Fedrilate

Source: Wikipedia, the free encyclopedia.
Fedrilate
Clinical data
Trade namesTussefan
ATC code
Identifiers
  • 4-morpholin-4-ylbutan-2-yl 4-phenyloxane-4-carboxylate
JSmol)
  • O=C(OC(CCN1CCOCC1)C)C3(c2ccccc2)CCOCC3
  • InChI=1S/C20H29NO4/c1-17(7-10-21-11-15-24-16-12-21)25-19(22)20(8-13-23-14-9-20)18-5-3-2-4-6-18/h2-6,17H,7-16H2,1H3 checkY
  • Key:RDEOYUSTRWNWLX-UHFFFAOYSA-N checkY
  (verify)

Fedrilate is a centrally acting

mucolytic by UCB in 1971, but was never brought to market in the US.[1] In the Netherlands, it has been marketed as Tussefan and in combination with guaifenesin as Tussefan expectorans.[2]

References

  1. ^ US patent 3567835, Henri Morren, "Mucolytic salts, compositions and process for treating mucus", issued March 2, 1971 
  2. ISBN 90-228-8006-0
    .



drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fedrilate&oldid=1172196349"